Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceMice, Inbred C57BLCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBlood CellsBone Marrow ExaminationTreatment OutcomeTime FactorsImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionImmunosuppressionStem Cell TransplantationAcute DiseaseLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationT-LymphocytesColony-Forming Units AssaySevere Combined ImmunodeficiencyRetrospective StudiesChimeraMyelodysplastic SyndromesSurvival AnalysisHLA AntigensHematologic DiseasesLeukocyte CountLung TransplantationCyclosporineBone DensityActuarial AnalysisLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesCell DifferentiationPancytopeniaOrgan TransplantationCarmustineSpleenGraft vs Tumor EffectSurvival RateCytarabineBlood Cell CountGraft vs Leukemia EffectCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorFlow CytometryMice, Inbred BALB CBone ResorptionErythrocytesMelphalanCells, CulturedDisease-Free SurvivalEtoposideLymphomaMultiple MyelomaAntigens, CD34Fatal OutcomeMice, KnockoutGranulocytesPrognosisInfection